Clinical trial
Multi-Center Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite
NCT04065711 is registered in ClinicalTrials.gov with Soliton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite
- Lead sponsor
- Soliton
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 20, 2019
- Completion date
- August 26, 2021
- Enrollment
- 67 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.